Camille T.
- Country
- France
- Department
- Medical oncology
Research Overview
- PREDOSTAR - PREventing second cancers with DOSTARlimab - A multicenter, open-label, randomized phase II study aiming to assess the clinical impact of dostarlimab on occurrence of second primary cancer in patients with cured primary cancer
- Randomized Phase II/III Study of Cabozantinib Maintenance Versus Best Supportive Care in Osteosarcoma Patients After First‑Line Chemotherapy (FOSTER‑CabOS)
- Phase 3 Double-Blind Study of Ivosidenib in Adults with IDH1-Mutant Locally Advanced or Metastatic Conventional Chondrosarcoma
Data & Insights
Has run more than one trial at 24 of 99 partner sites.
Specializations
Oncology Focus
Specialized in the treatment of rare sarcomas, particularly focusing on advanced and metastatic cases that require innovative therapeutic approaches.
- Metastatic Sarcoma Management
- Unresectable Tumor Treatment
Investigates advanced therapeutic solutions for patients with complex sarcoma presentations.
Immunotherapy Expertise
Focuses on combination immunotherapy approaches in oncology, specifically exploring the therapeutic potential of nivolumab and ipilimumab combinations.
- Novel Immunotherapy Protocols
- Targeted Cancer Treatment
Evaluates innovative immunotherapeutic strategies for rare cancer types.
Comparative Therapeutics
Conducts research comparing targeted therapy approaches with immunotherapy combinations in advanced sarcoma treatment.
- Treatment Efficacy Assessment
- Progressive Disease Management
Examines therapeutic outcomes in rare sarcoma subtypes using various treatment modalities.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.